Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041117 | SCV000064808 | benign | not specified | 2015-11-09 | criteria provided, single submitter | clinical testing | p.Gln3447His in exon 44B of TTN: This variant is not expected to have clinical s ignificance because it has been identified in 1% (106/9800) of African chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs79466278). |
Gene |
RCV000041117 | SCV000238081 | benign | not specified | 2015-06-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000232467 | SCV000286428 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839869 | SCV002100902 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839870 | SCV002100903 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839871 | SCV002100904 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839868 | SCV002100905 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003326340 | SCV004033837 | benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV003326340 | SCV005241382 | benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000041117 | SCV001800320 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000041117 | SCV001921590 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041117 | SCV001954331 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000041117 | SCV001969266 | benign | not specified | no assertion criteria provided | clinical testing |